Naproxen prevention in colorectal cancer
Ended Awarded Last action
- Contract number
- HHSN26100005
- Awardee
-
University Of Oklahoma UEI GY8NMUZQXVS7 Part of University Of Oklahoma
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $633,898
Award facts
- Contract value 100% obligated
- $633,898.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Oklahoma City, OK 73104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$2,384 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $636,282 |
About this award
This federal contract award was issued by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the University of Oklahoma (OU). The $633,898 firm fixed price delivery order is part of NCI's "Preclinical Agent Development Assays 2012-2016" indefinite delivery contract and supports research on the use of the drug naproxen for the prevention of colorectal cancer. The contract does not have a small business set-aside designation. As a subcontractor, Ohio State University will assist OU in determining the mechanism, administration, and dose-dependence of naproxen's effects on colorectal cancer suppression, as well as examining its impact on tumor formation in a mouse model. This research supports NCI's mission of advancing cancer prevention and treatment through preclinical development of novel drugs and therapies.
Quick answers
Who was awarded contract HHSN26100005?
HHSN26100005 was awarded to University Of Oklahoma by National Cancer Institute (National Institutes of Health) on September 18, 2013.
How much is contract HHSN26100005 worth?
The government has obligated $633,898 on HHSN26100005.
Is contract HHSN26100005 an order under another contract?
Yes. HHSN26100005 is a delivery order under HHSN261201200020I, an indefinite delivery contract, on Preclinical Agent Development Assays 2012-2016.
Was contract HHSN26100005 competed?
The extent of competition for HHSN26100005 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award